Home Why This Small Victory Against Short Sellers Might Be a Big Deal for Biotech Companies
 

Keywords :   


Why This Small Victory Against Short Sellers Might Be a Big Deal for Biotech Companies

2015-08-25 18:56:08| Biotech - Topix.net

Acorda Therapeutics, a small New York-based drug maker, just won a round in a rather obscure patent fight with hedge fund manager Kyle Bass. You haven't been following this? The case matters a great deal to the biotech industry, and the implications may stretch far beyond.

Tags: for small big short

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11 WEEZER / maladroit 12\"
23.11
23.11 6'1ML REV-S
23.11speak up storys
23.11190mm LS0713FL
23.11That's Moulton
23.11SEED
More »